CellSeed's Regenerative medicine technology
CellSeed continue to focus our efforts on commercializing cell sheet regenerative medicine to bring these products to market.
- IR Fiscal 2020 Earnings Results Presentation
- IR Mid-term Business Plan Fiscal Year 2021 to Fiscal Year 2023
- IR Summary of Consolidated Financial Results for the Year Ended December 31, 2020
- IR Announcement of the extension of Distribution Agreement with Thermo Fisher Scientific Inc.
- IR FY 2020 Financial results will be announced on February 12th.